Afya Ltd. (AFYA)
Surging Earnings Estimates Signal Upside for Afya (AFYA) Stock
Afya (AFYA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts See a 27.62% Upside in Afya (AFYA): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 27.6% in Afya (AFYA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Bamco Inc. NY Cuts Stock Holdings in Afya Limited $AFYA
Bamco Inc. NY lowered its position in shares of Afya Limited (NASDAQ: AFYA) by 11.4% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,729,805 shares of the company's stock after selling 221,559 shares during the period. Bamco Inc. NY
Afya Limited (AFYA) Q4 2025 Earnings Call Transcript
Afya Limited (AFYA) Q4 2025 Earnings Call Transcript
Afya (AFYA) Tops Q4 Earnings Estimates
Afya (AFYA) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.36 per share a year ago.
Are Investors Undervaluing Afya (AFYA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Afya Limited (AFYA) Q3 2025 Earnings Call Transcript
Afya Limited ( AFYA ) Q3 2025 Earnings Call November 12, 2025 5:00 PM EST Company Participants Renata Couto - Investor Relations Executive Manager Virgilio Deloy Gibbon - Chief Executive Officer Luis Andre Blanco - Chief Financial Officer Conference Call Participants Lucca Marquezini - Itaú Corretora de Valores S.A., Research Division Lucas Nagano - Morgan Stanley, Research Division Marcelo Santos - JPMorgan Chase & Co, Research Division Mirela Rodrigues de Oliveira - BofA Securities, Research Division Renan Prata - Citigroup Inc. Exchange Research Presentation Renata Couto Investor Relations Executive Manager Thank you for joining us for Afya's conference call.
Afya (AFYA) Q3 Earnings Beat Estimates
Afya (AFYA) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.32 per share a year ago.
Afya's Multiple Is Back To Reasonable Levels, But Market Saturation Is Real
Afya's Q2 2025 results were solid, but the stock faces headwinds from market saturation and regulatory changes in Brazil's medical education sector. Valuation is now more attractive after a 20%+ price drop, but risks from lower pricing power, increased competition, and new quality exams remain significant. The company is shifting capital allocation toward buybacks and dividends, signaling fewer expansion opportunities and a focus on shareholder returns.
Afya Limited (AFYA) Q2 2025 Earnings Call Transcript
Afya Limited (NASDAQ:AFYA ) Q2 2025 Earnings Conference Call August 13, 2025 5:00 PM ET Company Participants Luis Andre Carpintero Blanco - Chief Financial Officer Virgilio Deloy Capobianco Gibbon - Chief Executive Officer Conference Call Participants Flavio Yoshida - BofA Securities, Research Division Lucca Generali Marquezini - Itaú Corretora de Valores S.A., Research Division Marcelo Peev dos Santos - JPMorgan Chase & Co, Research Division Mauricio I Cepeda - Morgan Stanley, Research Division Renan Prata - Citigroup Inc. Exchange Research Samuel Campos Alves - Banco BTG Pactual S.A.
Best Growth Stocks to Buy for August 6th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today August 6th:
Best Growth Stocks to Buy for August 4th
PRIM, AFYA and JBL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 4, 2025.
